PRAM Trademark for Medical Diagnostic Instruments and Software

ChangeBridge: Trademarks - Medical Devices (Class 010)

Published March 26th, 2026

Detected March 28th, 2026

Summary

The USPTO has published the trademark application for 'PRAM' for use with medical diagnostic instruments, software, and related diagnostic services. The application was published for opposition on March 26, 2026, following a filing date of March 7, 2025.

View original document View source feed page

What changed

The United States Patent and Trademark Office (USPTO) has published trademark application TM79426219 for the mark 'PRAM'. This publication is for opposition and pertains to electromedical diagnostic instruments for evaluating various physiological conditions, medical diagnostic services, and recorded computer software for analyzing physiological arterial pressure waveform data. The application was filed on March 7, 2025, and published for opposition on March 26, 2026.

This action signifies the USPTO's preliminary approval of the trademark for use in commerce within the specified classes. Interested parties have a period to oppose the registration. For entities involved in medical device manufacturing or software development in this space, this publication is a standard procedural step. No immediate compliance actions are required by regulated entities, but monitoring the opposition period is advisable for those with potential conflicts.

Source document (simplified)

← USPTO Trademark Applications

PRAM

Published for Opposition TM79426219 Kind: published Mar 26, 2026

Abstract

Electromedical diagnostic instruments for the evaluation of hemodynamics; electromedical diagnostic instruments for the evaluation of homeostasis of a biological system; electromedical diagnostic instruments for the evaluation of heart-arterial circulation interaction; electromedical diagnostic instruments for evaluation of cardiac valvular insufficiencies; electromedical diagnostic instruments for evaluation of peripheral stenosis; electromedical diagnostic instruments for evaluation of neurovegetative system; electromedical diagnostic instruments for evaluation of response time of biohumoral indicators.; Medical diagnostic services for evaluation of hemodynamics; medical diagnostic services for evaluation of homeostasis of a biological system; medical diagnostic services for evaluation of heart-arterial circulation interaction; medical diagnostic services for evaluation of cardiac valvular insufficiencies; medical diagnostic services for evaluation of peripheral stenosis; medical diagnostic services for evaluation of neurovegetative system; medical diagnostic services for evaluation of response time of biohumoral indicators.; Recorded computer software for medical diagnostic instruments, namely, software for analyzing physiological arterial pressure waveform data and generating hemodynamic monitoring parameters for evaluation of hemodynamics; recorded computer software for medical diagnostic instruments, namely, software for analyzing physiological arterial pressure waveform data and generating hemodynamic monitoring parameters for evaluation of homeostasis of a biological system; recorded computer software for medical diagnostic instruments, namely, software for analyzing physiological arterial pressure waveform data and generating hemodynamic monitoring parameters for evaluation of heart-arterial circulation interaction; recorded computer software for medical diagnostic instruments, namely, software for analyzing physiological arterial pressure waveform data and generating hemodynamic monitoring parameters for evaluation of peripheral stenosis; recorded computer software for medical diagnostic instruments, namely, software for analyzing physiological arterial pressure waveform data and generating hemodynamic monitoring parameters for evaluation of neurovegetative system; recorded computer software for medical diagnostic instruments, namely, software for analyzing physiological arterial pressure waveform data and generating hemodynamic monitoring parameters for evaluation of response time of biohumoral indicators.